Table 4.
Marker | Cutoff | Centile | Sensitivity (95% CI) | Specificity (95% CI) | Positive predictive value (95% CI) | Negative predictive value (95% CI) |
---|---|---|---|---|---|---|
suPAR, ng/mL | 4.12 | 20 | 0.95 (0.91–0.98) | 0.21 (0.19–0.23) | 0.10 (0.09–0.10) | 0.98 (0.96–0.99) |
4.54 | 25 | 0.91 (0.87–0.96) | 0.26 (0.24–0.28) | 0.10 (0.10–0.11) | 0.97 (0.96–0.98) | |
6.70 | 50 | 0.70 (0.63–0.77) | 0.52 (0.50–0.54) | 0.12 (0.11–0.13) | 0.95 (0.94–0.96) | |
10.1 | 75 | 0.47 (0.40–0.55) | 0.75 (0.75–0.79) | 0.16 (0.13–0.18) | 0.94 (0.93–0.95) | |
D‐dimer, mg/L | 0.50 | 20 | 0.95 (0.92–0.98) | 0.21 (0.20–0.24) | 0.12 (0.11–0.12) | 0.97 (0.96–0.99) |
0.56 | 25 | 0.92 (0.88–0.96) | 0.26 (0.25–0.29) | 0.12 (0.12–0.13) | 0.97 (0.95–0.98) | |
1.03 | 50 | 0.78 (0.72–0.83) | 0.53 (0.50–0.56) | 0.15 (0.14–0.16) | 0.96 (0.94–0.97) | |
2.40 | 75 | 0.48 (0.41–0.55) | 0.77 (0.75–0.79) | 0.19 (0.16–0.21) | 0.93 (0.92–0.94) |
suPAR indicates soluble urokinase plasminogen activator receptor; and VTE, venous thromboembolism.